, Volume 1, Issue 1, pp 69–81 | Cite as

Malignant Pituitary Tumours

  • G.A. Kaltsas
  • A.B. Grossman
pituitary tumours malignancy metastases chemotherapy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Frost AE, Tenner S, Tenner M, Rollhauser C, Tabbara SO. ACTH-producing pituitary carcinoma presenting as cauda equina syndrome. Arch Pathol Lab Med 1995;119:93–96.Google Scholar
  2. 2.
    Selman WR, Laws ER, Scheithauer BW, Carpenter SM. The occurence of dural invasion in pituitary adenomas. J Neurosurg 1986;64:402–407.Google Scholar
  3. 3.
    Scheithauer BW, Kovacs KT, Laws ER, Randall RV. Pathology of invasive pituitary tumours with special reference to functional classification. J Neurosurg 1986;65:733–744.Google Scholar
  4. 4.
    Pernicone PJ, Scheithauer BW, Sebo TJ, et al. Pituitary carcinoma: A clinicopathological study of 15 cases. Cancer 1997;79:804–812.Google Scholar
  5. 5.
    Doniach I. Pituitary carcinoma. Clin Endocrinol 1992;37: 194–195. Oxford.Google Scholar
  6. 6.
    Popovic EA, Vattuone JR, Siu KA, Busmanis I, Pullar MJ, Dowling J. Malignant prolactinomas. Neurosurgery 1991; 29:127–130.Google Scholar
  7. 7.
    Doniach I. Pituitary carcinoma. In: Sheures R, Jenkins P, Hnou JA (eds.). Clinical Endocrine Oncology. Oxford: Blackwell Science Ltd., 1997:225–227.Google Scholar
  8. 8.
    Mountcastle RB, Roof BS, Mayfield RK, et al. Case report: Pituitary adenocarcinoma in an acromegalic patient: Response to bromocriptine and pituitary testing: A review of the literature on 36 cases of pituitary carcinoma. Am J Med Sci 1989;298:109–118.Google Scholar
  9. 9.
    Price PA. Cytotoxic chemotherapy for aggressive pituitary tumours. In: Grossman AB (ed.). Clinical Endocrinology. Oxford: Blackwell Sci Pub., 1992: 235–237.Google Scholar
  10. 10.
    Kuvoki M, Tanaka R, Yokoyama M, Shimbo Y, Ikuta F. Subarachnoid dissemination of a pituitary adenoma. Surg Neurol 1987;28:71–76.Google Scholar
  11. 11.
    Garrao AF, Sobrincho G, Oliveira P, et al. ACTH-producing carcinoma of the pituitary with haematogenic metastases. Eur J Endocr 1997;137:176–180.Google Scholar
  12. 12.
    Nudleman KL, Choi B, Kusske JA. Primary pituitary carcinoma: A clinical pathological study. Neurosurgery 1985; 16:90–95.Google Scholar
  13. 13.
    Wilson DF. Pituitary carcinoma occuring as middle ear tumour. Otolaryngol Head Neck Surg 1982;90:665–666.Google Scholar
  14. 14.
    Herman V, Fagin J, Gonsky R, Kovacs KT, Melmed S. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 1990;71:1427–1433.Google Scholar
  15. 15.
    Farrell WE, Talbot JA, Bicknell EJ, Simpson D, Clayton RN. Genomic sequence analysis of a key residue (Arg 183) in human Gaq in invasive non-functional pituitary adenomas. Clin Endocrinol 1997;47:241–244.Google Scholar
  16. 16.
    Luzi P, Miracco C, Lio R, et al. Endocrine inactive pituitary carcinoma metastasizing to cervical lymph nodes: A case report. Hum Pathol 1987;18:90–92.Google Scholar
  17. 17.
    Taylor WA, Uttley D, Wilkins PR. Multiple dural metastases from a pituitary adenoma. J Neurosurg 1994;81:624–626.Google Scholar
  18. 18.
    Thapar K, Yamada Y, Scheithauer B, Kovacks K, Yamada S, Stefaneanu L. Assessment of mitotic activity in pituitary adenomas and carcinomas. Endocr Pathol 1996;7:215–221.Google Scholar
  19. 19.
    Bates AS, Farrell WE, Bicknell EJ, et al. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab 1997;82:818–824.Google Scholar
  20. 20.
    Walker JD, Grossman AB, Anderson JV, et al. Malignant prolactinoma with extracanial metastases: a report of three cases. Clin Endocrinol 1993;38:411–419.Google Scholar
  21. 21.
    Hurel SJ, Harris PE, McNicol AM, Foster S, Kelly WF, Baylis PH. Metastatic prolactinoma: Effect of octreotide, cabergoline, carboplatin and etoposide; immunocytochemical analysis of protooncogene expression. J Clin Endocrinol Metab 1997;82:2962–2965.Google Scholar
  22. 22.
    Assai A, Matsutani M, Nobuaki F, Tarakura K. Malignant growth hormone-secreting pituitary adenoma with haematogenous dural metastasis: Case report. Neurosurgery 1988;22:1091–1094.Google Scholar
  23. 23.
    Muhr C, Bergstom M, Lundberg PO, et al. Malignant prolactinoma with multiple intracranial metastases studied with positron emmision tomography. Neurosurgery 1988;22: 374–379.Google Scholar
  24. 24.
    Yamashita S, Izumi M, Nagataki S. Acromegaly and pituitary carcinoma. Ann Intern Med 1992;117:1057.Google Scholar
  25. 25.
    Gasser RW, Finkenstedt G, Skrabal F, et al. Multiple intracranial metastases from a prolactin secreting pituitary tumour. Clin Endocrinol 1985;22:17–27.Google Scholar
  26. 26.
    Landolt AM. Ultrastructure of human sella tumours. Acta Neurochir (Suppl) 1975;22:94.Google Scholar
  27. 27.
    Martin NA, Hales M, Wilson CB. Cerebellar metastasis from a prolactinoma during treatment with bromocriptine. J Neurosurg 1981;55:615–619.Google Scholar
  28. 28.
    Hashimoto N, Handa H, Nishi S. Intracranial and intraspinal dissemination from a growth hormone-secreting pituitary tumour. J Neurosurg 1986;64:140–144.Google Scholar
  29. 29.
    Hardy J. Transphenoidal microsurgical treatment of pituitary tumours. Recent advances in the diagnosis and treatment of pituitary tumours. New York: Raven Press, 1979: 375–378.Google Scholar
  30. 30.
    Stewart PM, Carey MP, Graham CT, Wright AD, London R. Growth hormone secreting pituitary carcinoma: A case report and literature review. Clin Endocrinol 1992;37: 189–195.Google Scholar
  31. 31.
    Burrow GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs KT. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 1981;304:156–158.Google Scholar
  32. 32.
    Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: Occult adenomas in the general population. Ann Intern Med 1994;120:817–820.Google Scholar
  33. 33.
    Faglia G. Epidemiology and pathogenesis of pituitary adenomas. Acta Endocrinol 1993;129:1–5.Google Scholar
  34. 34.
    Shimon I, Melmed S. Pituitary tumour pathogenesis. J Clin Endocrinol Metab 1997;82:1675–1681.Google Scholar
  35. 35.
    Boggild MD, Jenkinson S, Pistorelo M, et al. Molecular genetic studies of sporadic pituitary tumours. J Clin Endocrinol Metab 1994;78:387–392.Google Scholar
  36. 36.
    Golland R, Kosty M, Cheney C, Copeland B, Bordin G. Prolactin secreting pituitary carcinoma with implants in the cheek pouch and metastases to the ovaries. Cancer 1995;76:1814–1820.Google Scholar
  37. 37.
    Atienza DM, Vigersky RJ, Lack E, et al. Prolactin producing pituitary carcinoma with pulmonary metastases. Cancer 1991;68:1605–1610.Google Scholar
  38. 38.
    Cohen H, Dible JH. Pituitary basophilism associated with a basophil carcinoma of the anterior lobe of the pituitary gland. Brain 1937;59:395–407.Google Scholar
  39. 39.
    Fitzgibbons PL, Appley AJ, Turner RR, et al. Flow cytometric analysis of pituitary tumours. Correlation of nuclear antigen p105 and DNA content with clinical behaviour. Cancer 1988;62:1556–1560.Google Scholar
  40. 40.
    Saunter D, Saeger W. Invasiveness of pituitary adenomas. Pathol Res Pract 1991;187:632–636.Google Scholar
  41. 41.
    Ikeda H, Yoshimoto Y. The relationship between c-myc protein expression, the bromodeoxyuridine labelling index and the biological behaviour of pituitary adenomas. Acta Neuropathol 1992;83:361–364.Google Scholar
  42. 42.
    Bravo R, Frank R, Blundell PA, McDonald-Bravo H. Cyclin PCNA is the auxillary protein of DNA polymerase-delta. Nature 1987;326:515–517.Google Scholar
  43. 43.
    Cusimano MD, Ohori P, Martinez JA, Jungreis C, Wright D. Pituitary carcinoma. Skull Base Surg 1994;4:46–51.Google Scholar
  44. 44.
    Williamson EA, Daniels M, Foster S, Kelly WF, Kendall-Taylor P, Harris PE. Gsa and Gi2a mutations in clinically non-functioning pituitary tumours. Clin Endocrinol 1994; 41:815–820.Google Scholar
  45. 45.
    Karga HJ, Alexander JM, Hedley E.T, Klibansky A, Jameson JL. ras mutations in human pituitary tumours. J Clin Endocrinol Metab 1992;74:914–919.Google Scholar
  46. 46.
    Cai WY, Alexander JM, Hedley-Whyte ET, et al. Ras mutations in human probotinomas and pitutary carcinomas. J Clin Endocrinol 1994;78:89–93.Google Scholar
  47. 47.
    Takino H, Herman V, Weiss M, Melmed M. Purine binding factor (nm23) gene expression in pituitary tumours:marker of adenoma invasiveness. J Clin Endocrinol Metab 1995; 80:1733–1738.Google Scholar
  48. 48.
    Pei L, Melmed S, Scheithauer B, Kovacks K, Benedict WF, Prager D. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumours:evidence for a chromosome 12 tumour suppressor gene other than RB. Cancer Res 1995;55: 1613–1616.Google Scholar
  49. 49.
    Woloschak M, Roberts JL, Post KD. Loss of heterozygosity at the retinoblastoma locus in human pituitary tumours. Cancer 1994;74:693–696.Google Scholar
  50. 50.
    Cryns VL, Alexander JM, Klibanski A, Arnold A. The retinoblastome gene in human pituitary tumours. J Clin Endocrinol Metab 1993;77:644–646.Google Scholar
  51. 51.
    Fearon ER, Vogelstein B. A genetic model for colorectal tumourigenesis. Cell 1990;61:759–767.Google Scholar
  52. 52.
    Dahia PLM, Aguiar RCT, Honegger J, et al. Mutation and expression analysis of the P27/kip1 gene in corticotrophin-secreting tumours. Oncogene 1997(1998)16:69–76.Google Scholar
  53. 53.
    Hu N, Gutsmann A, Herbert DC, Bradley A, Lee WH, Lee EY. Heterozygous Rb-1 delta/+ mice predisposed to tumours of the pituitary gland with a nearly complete penetrance. Oncogene 1994;9:1021–1027.Google Scholar
  54. 54.
    Fero ML, Rivkin M, Tasch M, et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 1996; 85:733–744.Google Scholar
  55. 55.
    Peterson T, McFarlane IA, McKenzie JM, Shaw MD. Prolactin secreting pituitary carcinoma. J Neurol Neurosurg Psychiatry 1992;55:1205–1206.Google Scholar
  56. 56.
    Cartwright DM, Miller TR, Nasr AJ. Fine needla aspiration biopsy of pituitary carcinoma with cervical lymph node metastases: A report of two cases and review of the literature. Diagn Cytopathol 1994;11:68–73.Google Scholar
  57. 57.
    McCormick PC, Post KD, Kandji AD, Hayes AP. Malignant tumours of the pituitary gland. Arch Neurol 1992;49: 555–558.Google Scholar
  58. 58.
    Chiang MF, Brock M, Patt S. Pituitary metastasis. Neurochirurgica 1990;33:127–131.Google Scholar
  59. 59.
    Landgraf R, Rieder G, Schmiedek P, Clados D, Bise K, Werder K. Hormoneactive intradural spinal metastasis from a prolactinoma-a case report. Klin Neurosurg Psychol 1985; 63:379–384.Google Scholar
  60. 60.
    Saeger W, Bosse U, Pfinst E, et al. Prolacting-secreting pituitary carcinoma. Case report of a very rare metastasizing tumour. Pathologe 1995;16:354–358.Google Scholar
  61. 61.
    Bates AS, Buckley N, Boggild EJ, et al. Clinical and genetic changes in a case of a Cushing's syndrome. Clin Endocrinol 1995;42:663–670.Google Scholar
  62. 62.
    Lormeau B, Miossec P, Sibony M, Valenci P, Attali J. Adrenocorticotropin-producing pituitary carcinoma with liver metastasis. J Endocrinol Invest 1997;20:230–236.Google Scholar
  63. 63.
    Myles ST, Johns RD, Curry B. Carcinoma of the pitutary gland with metastases to the bone. Can J Neurol Sci 1984;11:310–317.Google Scholar
  64. 64.
    Dayan C, Guilding T, Hearing S, et al. Biochemical cure of recurrent acromegaly by resection of cervical spinal canal metastases. Clin Endocrinol 1996;44:597–602.Google Scholar
  65. 65.
    Greenman Y, Woolf P, Coniglio J, et al. Remission of acromegaly caused by pituitary carcinoma after surgical excision og growth-hormone secreting metastasis detected by 111-Indium pentetreotide scan. J Clin Endocrinol Metab 1997;81:1628–1633.Google Scholar
  66. 66.
    Beauchesne P, Trouillas J, Brral F, Brunon J. Gonadotropic pituitary carcinoma: Case report. Neurosurgery 1995;37: 810–816.Google Scholar
  67. 67.
    Mixson AJ, Friedman TC, Katz DA, et al. Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab 1993;76:529–533.Google Scholar
  68. 68.
    Jamjoom A, Moss T, Coakham H, Jamjoom AZ, Antony P. Cervical lymph node metastases from a pituitary carcinoma. Br J Neurosurg 1994;8:87–92.Google Scholar
  69. 69.
    Kaizer FE, Orth DN, Mukai K, Oppenhaimer JH. A pituitary parasellar tumour with extracranial metastases and high, partially suppressible levels of adrenocorticotropin and related peptides. J Clin Endocrinol Metab 1983;57: 649–653.Google Scholar
  70. 70.
    Gabrilove JL, Anderson PJ, Halmi NS. pituitary proopiomelanocortin-cell carcinoma occuring in conjunction with glioblastoma in a patient with Cushing's disease and subsequent Nelson's syndrome. Clin Endocrinol 1986;25: 117–126.Google Scholar
  71. 71.
    Moberg A. A case of pituitary chromophobe adenoma with metastases in the heart. Acta Pathol Microbiol Scand 1959; 45:243–249.Google Scholar
  72. 72.
    Sheldon WH, Golden A, Bondy PK. Cushing's syndrome produced by pituitary baseophil carcinoma with hepatic metastases. Am J Med 1954;17:134–142.Google Scholar
  73. 73.
    Queiroz LS, Facure NO, Facure JJ, Modesto NP, deFaria JL. Pituitary carcinoma with liver metastasis and Cushing's syndrome. Arch Pathol 1975;99:32–35.Google Scholar
  74. 74.
    Nawata H, Higushi K, Ikuyama S, et al. Corticotropin-releasing hormone and adrenocorticotropin-producing pituitary carcinoma with metastases to the liver and lung in a patient with Cushing's disease. J Clin Endocrinol Metab 1990;71:1068–1073.Google Scholar
  75. 75.
    Scheithauer BW, Randall RV, Lavos ERJ, Kovacs KT, Horvath E, Whitaker MD. Prolactin cell crcinoma of the pituitary. Cancer 1985;55:598–604.Google Scholar
  76. 76.
    Tonner D, Belding P, Moore SA, Schlechte JA. Intracranial dissemination of an ACTH secreting pituitary neoplasm-A case report and review of the literature. J Endocrinol Invest 1992;15:387–391.Google Scholar
  77. 77.
    Cohen DL, Diengdoh JV, Thomas DGT, Himsworth RL. An intracranial metastasis from a PRL secreting pituitary tumour. Clin Endocrinol 1983;18:259–264.Google Scholar
  78. 78.
    Figarella-Branger D, Trouillas J, Morange I. Prolactin pituitary carcinoma with multiple systemic metastasis. Endocr Path 1992;3(Suppl 1):S11–S12.Google Scholar
  79. 79.
    Hoi Sang U, Johnson C. Metastatic prolactin secreting pituitary adenoma. Hum Pathol 1984;15:94–96.Google Scholar
  80. 80.
    Epstein A, Epstein BS, Molho L, Zimmerman HM. Carcinoma of the pituitary gland with metastases to the spinal cord and roots of the cauda equina. J Neurosurg 1964;21:846–853.Google Scholar
  81. 81.
    Gesundheit N, Petrick PA, Nissim M. Thyrotropin secreting pituitary adenomas: Clinical and biochemical heterogenisity. Ann Intern Med 1989;111:827–835.Google Scholar
  82. 82.
    Hsu DW, Hakim F, Biller BMK, et al. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 1993;78:753–761.Google Scholar
  83. 83.
    Reubi JC, Mauer R, von Werder K, Torhorst J, Klinj JG, Lamberts SW. Somatostatin receptors in human endocrine tumours. Cancer Resear 1987;47:551–558.Google Scholar
  84. 84.
    Papotti M, Limone P, Riva C, Gatti G, Bussolati G. Malignant evolution of an ACTH-producing pituitary tumour treated with intrasellar implantation of 90Y. Appl Pathol 1984;2:10–21.Google Scholar
  85. 85.
    Shrieve DC, Tarbell NJ, Alexander E3, et al. Stereotactic radiotherapy: A technique for dose optimization and escalation for intracranial tumors. Acta Neurochir Suppl 1994;62: 118–123.Google Scholar
  86. 86.
    Lippman SM, Mendelsohn G, Trump D, Wells JS, Baylin S. The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma. J Clin Endocrinol Metab 1982;54:233–240.Google Scholar
  87. 87.
    Yin KJ. Distribution of somatostatin mRNA containing neurons in the primary pain relaying nuclei in the rat. Anat Rec 1995;241:579–584.Google Scholar
  88. 88.
    Davis JRE, Sheppard MC, Heath DA. Giant invasive prolactinoma: A case report and review of nine further cases. Quar J Med 1990;74:259–264.Google Scholar
  89. 89.
    Murphy FY, Vesely DL, Jordan RM, Flanigan S, Kohler PO. Giant invasive prolactinomas. Am J Med 1987;83:995–1002.Google Scholar
  90. 90.
    Vaughan NJA, Laroche CM, Goodman I, Davies MJ, Jenkins JS. Pituitary Cushing's disease arising from a previously non-functional corticotrophic chromophobe adenoma. Clin Endocrinol 1985;22:147–153.Google Scholar
  91. 91.
    Kasperlik-Zaluska AA, Wislawski J, Kaniewska J, Zborzil J, Frankiewicz E, Zgliczynski S. Cytostatics for acromegaly. Marked improvement in a patient with an invasive pituitary tumour. Acta Endocrinol 1987;116:347–349.Google Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • G.A. Kaltsas
  • A.B. Grossman
    • 1
  1. 1.Department of EndocrinologySt. Bartholomew's HospitalLondonU.K.

Personalised recommendations